🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

150,36 USD

Máx. histórico

156,45

71 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-3,89%

Rango 52 semanas

82,91 – 156,92

Variación hoy

+3,93%

Cierre anterior

144,67

Rango de hoy

146,05 – 150,40

Volumen hoy

10.698.412

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
155,01 (puede no estar actualizado)
Dividend yield
2,35% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,26%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/03/2021 72,92 73,10 71,86 72,59 -0,22% 1,70% 10.700.918
24/03/2021 72,59 73,17 72,43 72,75 -0,04% 1,01% 9.135.416
23/03/2021 73,56 73,78 72,55 72,78 -1,60% 1,67% 11.651.245
22/03/2021 72,33 74,43 72,08 73,96 +0,00% 3,25% 11.352.879
19/03/2021 73,71 74,67 72,54 73,96 +0,31% 2,89% 58.225.203
18/03/2021 73,72 74,61 73,67 73,73 -0,04% 1,27% 14.274.179
17/03/2021 73,22 73,95 72,49 73,76 +0,64% 1,99% 17.533.878
16/03/2021 72,66 73,64 72,65 73,29 +0,76% 1,35% 15.697.887
15/03/2021 72,04 73,05 71,64 72,74 +2,18% 1,96% 17.999.295
12/03/2021 70,64 71,46 70,60 71,18 -0,04% 1,22% 11.493.940
11/03/2021 71,46 71,91 71,17 71,21 -0,17% 1,03% 13.205.324
10/03/2021 71,34 71,78 70,71 71,34 +0,84% 1,51% 12.827.310
09/03/2021 71,15 72,00 70,73 70,74 -0,04% 1,78% 14.189.920
08/03/2021 70,96 72,10 70,04 70,77 +1,42% 2,90% 15.391.347
05/03/2021 69,19 70,05 68,71 69,78 +1,33% 1,93% 12.241.164
04/03/2021 69,83 69,96 68,44 68,86 -1,54% 2,19% 15.975.188
03/03/2021 69,48 70,35 69,10 69,94 +0,62% 1,80% 13.939.972
02/03/2021 69,50 70,12 69,08 69,51 +0,65% 1,50% 16.047.290
01/03/2021 69,86 70,03 68,87 69,06 -0,33% 1,65% 12.594.864
26/02/2021 71,03 71,29 69,22 69,29 -2,68% 2,92% 17.644.862
25/02/2021 70,81 71,56 70,69 71,20 +0,07% 1,24% 10.906.955
24/02/2021 71,37 71,82 70,98 71,15 +0,04% 1,18% 9.838.834
23/02/2021 71,84 72,48 71,05 71,13 -0,52% 1,99% 10.900.458
22/02/2021 71,09 71,62 70,35 71,50 +0,83% 1,79% 8.612.464
19/02/2021 71,98 72,05 70,86 70,91 -1,46% 1,66% 12.388.198
18/02/2021 71,82 72,40 71,60 71,96 -0,17% 1,12% 10.004.627
17/02/2021 71,05 72,58 70,96 72,08 +1,74% 2,27% 13.876.463
16/02/2021 71,92 71,98 70,66 70,85 -1,00% 1,83% 9.734.453
12/02/2021 71,30 71,67 71,13 71,56 +0,35% 0,76% 6.738.116
11/02/2021 71,38 71,66 70,83 71,32 -0,20% 1,16% 8.780.982